Opinion
Video
Drug Delivery Systems in NMIBC
Author(s):
An expert discusses how non–muscle invasive bladder cancer (NMIBC) treatment involves evolving delivery systems, transitioning from traditional systemic and intravesical approaches to advanced targeted technologies. Current research focuses on innovative platforms such as nanoparticle carriers, thermosensitive hydrogels, and personalized molecular delivery mechanisms to improve therapeutic efficacy and minimize systemic toxicity.
Video content above is prompted by the following:
- Please provide a brief overview of delivery systems that are available to patients for treatment of NMIBC (ie, systemic IV delivery and bladder delivery systems).
- Discuss ongoing studies with investigational delivery systems in different subpopulations of NMIBC.
Related Content
